MENU
+Compare
PHAT
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$14.88
Change
+$0.26 (+1.78%)
Capitalization
1.04B

PHAT Phathom Pharmaceuticals Forecast, Technical & Fundamental Analysis

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company... Show more

PHAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PHAT with price predictions
Nov 12, 2025

Momentum Indicator for PHAT turns positive, indicating new upward trend

PHAT saw its Momentum Indicator move above the 0 level on November 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 79 similar instances where the indicator turned positive. In of the 79 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where PHAT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for PHAT just turned positive on November 12, 2025. Looking at past instances where PHAT's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

PHAT moved above its 50-day moving average on October 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PHAT advanced for three days, in of 285 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 147 cases where PHAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PHAT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

PHAT broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PHAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.439). P/E Ratio (0.000) is within average values for comparable stocks, (63.753). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.001). Dividend Yield (0.000) settles around the average of (0.046) among similar stocks. P/S Ratio (7.174) is also within normal values, averaging (322.723).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PHAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
PHAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PHAT is expected to report earnings to rise 91.73% to -28 cents per share on March 03

Phathom Pharmaceuticals PHAT Stock Earnings Reports
Q4'25
Est.
$-0.29
Q3'25
Beat
by $0.32
Q2'25
Beat
by $0.12
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.42
The last earnings report on October 30 showed earnings per share of -15 cents, beating the estimate of -46 cents. With 581.86K shares outstanding, the current market capitalization sits at 1.04B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Campus Drive
Phone
+1 877 742-8466
Employees
452
Web
https://www.phathompharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JGICX79.850.33
+0.41%
Janus Henderson Growth And Income C
DSMZX10.87-0.01
-0.09%
Destinations Small-Mid Cap Equity Z
APDRX36.59-0.04
-0.11%
Artisan Global Opportunities Advisor
RWGIX5.46-0.01
-0.18%
Wedgewood Institutional
NWADX22.11-0.16
-0.72%
Nationwide Loomis All Cap Gr Eagle

PHAT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with QCLS. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then QCLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PHAT
1D Price
Change %
PHAT100%
+1.81%
QCLS - PHAT
39%
Loosely correlated
+7.62%
RGNX - PHAT
37%
Loosely correlated
+0.43%
ATRA - PHAT
36%
Loosely correlated
-0.72%
URGN - PHAT
34%
Loosely correlated
+6.39%
PDSB - PHAT
33%
Loosely correlated
-9.08%
More